Methyl iodide → HCID 58577771, 화합물

HRID 1044235노트

반응식

HRID 1044235 반응식
[H-].[Na+].[CH3:3][S:4]([C:7]1[NH:11][C:10]2[CH2:12][CH2:13][CH2:14][CH2:15][C:9]=2[N:8]=1)(=[O:6])=[O:5].[CH3:16]I.[Cl-].[Cl-].[Ca+2]>CN(C=O)C.CO>[CH3:16][N:11]1[C:10]2[CH2:12][CH2:13][CH2:14][CH2:15][C:9]=2[N:8]=[C:7]1[S:4]([CH3:3])(=[O:5])=[O:6]

참가 물질

7

반응물 4

HCID 6328Methyl iodideHCID 24758Sodium hydrideHCID 5284359Calcium ChlorideHCID 585774122-(methylsulfonyl)-4,5,6,7-tetrahydro-1H-benzimidazole

생성물 1

HCID 58577771HCID 58577771, 화합물

시약·촉매·용매 2

HCID 887Methanol용매HCID 6228Dimethylformamide용매

실험 절차

Sodium hydride (55.8 mg) (60% in mineral oil) was added to a solution of 2-(methylsulfonyl)-4,5,6,7-tetrahydro-1H-benzimidazole (233 mg) and MeI (0.080 mL) in DMF (dry) (10 mL) at room temperature. The mixture was stirred at room temperature under a dry atmosphere (CaCl2 tube) for 1 h. The reaction mixture was diluted with MeOH (2 mL), and concentrated in vacuo. The residue was purified by column chromatography (silica gel, eluted with 0%-30% EtOAc in hexane) to give 1-methyl-2-(methylsulfonyl)-4,5,6,7-tetrahydro-1H-benzimidazole (200 mg) as a white solid.

후처리

  1. concentrationconcentrated in vacuo
  2. customThe residue was purified by column chromatography (silica gel, eluted with 0%-30% EtOAc in hexane)

출처 및 근거

ORD 기록
ord-b9a6329fc8394a769b689cc3fc834735
출처 데이터셋
uspto-grants-2013_10
특허 번호
US08563575B2

반응 노트

불러오는 중…